Drug Shortage Report for DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, USP

Last updated on 2022-05-18 History
Report ID 157671
Drug Identification Number 02369567
Brand name DIPHENHYDRAMINE HYDROCHLORIDE INJECTION
Common or Proper name DiphenhydrAMINE Hydrochloride Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) DIPHENHYDRAMINE HYDROCHLORIDE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 1mL
ATC code R06AA
ATC description ANTIHISTAMINES FOR SYSTEMIC USE
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-03-29
Estimated end date 2022-05-20
Actual end date 2022-05-17
Shortage status Resolved
Updated date 2022-05-18
Company comments Due to unforeseen circumstances, we have encountered a supply interruption.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-05-18 French Compare
v5 2022-05-18 English Compare
v4 2022-05-02 French Compare
v3 2022-05-02 English Compare
v2 2022-03-31 French Compare
v1 2022-03-31 English Compare

Showing 1 to 6 of 6